Join Zack Lynch at Stanford Business School tonight where he'll be moderating a panel discussion between executives of several early stage companies in neuropharmaceutical discovery and development.

Among those who'll be sharing their perspective: Jeffrey Ostrove, CEO of Ceregene; David Summa, President and CEO of Acumen Pharmaceuticals; and Thorsten Melcher, Vice President of Discovery at Saegis Pharmaceuticals.

More info's available on Brain Waves, Zack's Industry Insider on neurotechnology.